
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CEVIY and 80,000+ other tickers.
See exactly how CEVIY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CEVIY and 80,000+ other tickers.
China Everbright Limited is a diversified financial conglomerate that operates primarily in Hong Kong and Mainland China, with its core business encompassing both robust investment strategies and comprehensive financial service provisions. The company actively deploys capital into a wide array of ventures, specifically targeting unlisted equity securities and equity derivatives. Its strategic investment portfolio spans high-growth sectors such as the new economy, cutting-edge artificial intelligence, advanced manufacturing, renewable energy, and the medical and senior healthcare industries…
No recent news available.